Premature Ovarian Insufficiency (POI) is a major challenge in women’s health that encompasses psychological and emotional aspects alongside long-term clinical consequences. Beyond its direct impact on reproductive function, this condition significantly reduces quality of life, manifesting through dynamic changes in the musculoskeletal and sarcopenic systems, increased cardiovascular risks, dystrophic processes of the genitourinary tract, adverse changes in sexuality and sexual health, as well as neurological and cognitive dysfunction. Although hormone therapy can alleviate these effects, many questions remain regarding optimal management approaches for premature ovarian insufficiency.<\/p>\n
A new study<\/a> published in the journal BMJ Global Health<\/i><\/a> provides an interesting perspective on this topic, drawing upon the extensive database of the Demographic and Health Surveys (DHS). This standardized study covers more than 90 low- and middle-income countries. These insights are highly valuable as they draw parallels between the prevalence of POI and economic status, marital status, healthcare access, ethno-cultural characteristics, education and awareness levels, and other social patterns.<\/p>\n Examining our own country from this point of view is always compelling; however, evaluating statistical metrics with a similar level of comprehensiveness in Georgia is difficult. Viewing our national reality through the same lens must rely primarily on clinical practice and individual case observations.<\/p>\n As indicated by the modern definition and nosological nomenclature, POI is defined as the functional depletion of the ovaries before the age of 40 (premature insufficiency), while a similar process occurring between the ages of 40 and 45 is termed early depletion. From age 45 onward, menopause is considered timely, despite its recognized average age of 50\u201351 years (more precisely, 51.7 years). Naturally, the younger the physiologically chronological age at which estrogen deficiency occurs, the more frequent and severe the associated acute symptoms and long-term somatic consequences become.<\/p>\n Pathogenetic Aspects<\/strong><\/p>\n Recognized risk factors and predictors include genetic factors (16%), family history, early-life history (maternal history during pregnancy, being a twin, malnutrition), so-called “menstrual factors” (early menarche, short-interval cycles), low parity or a history of nulliparity, low body mass index, tobacco use, social status, urbanization, occupation, and associations with various infections. In clinical practice, these potential predictors are clarified through detailed history-taking. However, it is difficult to establish a definitive rule; the primary focus is oriented toward familial predisposition among first-degree relatives.<\/p>\n One correlative pattern is the association with autoimmune diseases, including autoimmune thyroiditis, type 1 diabetes, autoimmune hypocorticism, and autoimmune hepatitis, among others. Post-pandemic immune dysmodulation cannot be ruled out as a contributing factor, given that recorded cases of POI have increased 3.5-fold over the past three years. Equally critical are environmental factors, such as intoxication with chemical disruptors, heavy metals (cadmium, thallium, arsenic), organic pollutants (pesticides and industrial chemicals), and plasticizers (phthalates, bisphenols).<\/p>\n In the context of Georgia, establishing direct associative links with environmental factors is challenging; however, given local ecological conditions, their potential impact is plausible. Some studies have highlighted changes in circulating factors (vitamins E and C, coenzyme Q, micronutrients, and alterations in the microbiota) captured alongside POI. Although a confirmed causal relationship with its pathogenesis has not been proven, a predisposing role cannot be excluded.<\/p>\n In terms of socioeconomic predictors, the experiences of low- and middle-income countries also apply to Georgia, though the national context exhibits its own distinct features. The level of education, accessibility of healthcare services, public awareness, and the social effects of urbanization reveal unique correlations within our reality. The majority of POI patients present to clinics via self-referral, driven by self-sourced information, everyday suspicions, and a desire for targeted evaluation. The primary focus of their clinical workup is a pelvic ultrasound and the subsequent radiological report, looking specifically for the presence of functional structures in the ovary that are inadequate for the patient’s age and stage.<\/p>\n Iatrogenic and Idiopathic Forms<\/strong><\/p>\n The clinical scenario is entirely different when dealing with iatrogenic ovarian insufficiency\u2014a reduction in ovarian reserve resulting from medical interventions. These types of interventions include any form of surgery on the pelvic organs. First and foremost are surgical interventions performed directly on the ovarian structure, whether urgent or elective (such as surgery for ovarian cyst apoplexy, torsion, or vascular compromise); even a partial resection impacts the follicular reserve of that specific ovary. Depending on the scale of the procedure, adnexectomy or oophorectomy may be performed, which practically halves the remaining reserve. Hysterectomy, even without surgical intervention on the ovaries, affects a certain category of women by disrupting ovarian trophism and blood supply, thereby implying functional insufficiency earlier than standard timelines. Iatrogenic insufficiency also includes gonadotoxic medical interventions, such as chemotherapy, cytotoxic therapy, brachytherapy, various modalities of radiation therapy, and hematopoietic stem cell transplantation. Following certain types of treatment, ovarian function may be reversible, but in most cases, it is irreversible or declines sharply over time.<\/p>\n In this regard, genital endometriosis\u2014specifically the invasive form of the process within the ovary\u2014is a highly prevalent and critical gynecological issue. On one hand, surgical intervention indicated for an ovarian endometrioma severely damages the ovarian reserve; on the other hand, the chronically progressive nature of the disease over time is capable of causing quantitative and qualitative damage to the functional elements and follicles of the ovary, even in the absence of surgery.<\/p>\n The majority of non-iatrogenic POI cases are associated with genetic diseases, chromosomal abnormalities, or structural defects in gonadotropins, which are linked to oxidative stress, mitochondrial DNA mutations, and subsequent irreversible dysfunction. Idiopathic (non-iatrogenic) POI is a diagnosis of exclusion. It is difficult to identify and utilize specific diagnostic tools for the aforementioned factors in daily clinical practice. These include chromosomal abnormalities (mostly X-linked conditions, complex mosaicism of Turner syndrome like 45,X\/47,XXX, Fraccaro-Ivanisevic syndrome [47,XXX], and fragile X [FMR1] gene premutations) as well as rare, non-standard investigations (primarily limited to research settings) designed to detect categories of genes associated with molecular defects, cellular dysfunction, or genomic abnormalities involved in DNA repair, meiosis, follicular growth, metabolism, or mitochondrial stress.<\/p>\n In reality, the minimum workup for this category of patients includes:<\/p>\n A detailed clinical history<\/p>\n A history of secondary amenorrhea lasting at least 4 months<\/p>\n Measurement of serum gonadotropins (predominantly Follicle-Stimulating Hormone [FSH])<\/p>\n Ultrasonic evaluation of the antral follicle count (AFC) in the ovaries<\/p>\n Measurement of Anti-M\u00fcllerian Hormone (AMH) for interested individuals<\/p>\n Within the Georgian medical framework, this diagnostic workup is entirely acceptable, feasible, integrated into clinical practice, and widely accessible.<\/p>\n The associations between POI, fertility, and reproductive prognosis are highly topical. It is established that spontaneous pregnancy occurs in 2.5% of women within 2 to 8 years following a diagnosis of non-iatrogenic POI, and in 4.8% within 1 year. Despite a prognosis that is not particularly promising over the long term, reproductive technologies offer supportive, fertility-oriented interventions. These include in vitro<\/i> activation (IVA) of folliculogenesis in ovarian tissue obtained via biopsy, the administration of mesenchymal stem cells, and platelet-rich plasma (PRP) injections into the ovary. At the stage of early diagnosis, any form of POI warrants the consideration of fertility preservation (cryopreservation of oocytes, embryos, or ovarian tissue) or oocyte donation to achieve fertility in irreversible situations. While diagnosis and management (hormone replacement therapy with sex steroids) are readily accessible in Georgia, utilizing various forms of reproductive technologies to preserve fertility remains difficult\u2014not in terms of the availability of medical services, but from a financial standpoint.<\/p>\n Regarding the management of POI, the cornerstone is hormone replacement therapy (HRT) using sex steroids. While similar therapy for menopausal-aged women is termed Menopausal Hormone Therapy (MHT), the designation of Hormone Replacement Therapy is preserved for the POI patient category as it is psychologically less traumatic. This is particularly relevant given that therapy for this cohort spans a prolonged period, continuing at least until the average age of natural menopause (50\u201351 years).<\/p>\n The primary aspect of management involves delicate counseling, comprehensive information sharing, and psychological support. This facet is generally lacking within the structure of Georgian medicine and requires refinement through specific education and specialized training.<\/p>\n","protected":false},"excerpt":{"rendered":" Premature Ovarian Insufficiency (POI) is a major challenge in women’s health that encompasses psychological and emotional aspects alongside long-term clinical consequences. Beyond its direct impact on reproductive function, this condition significantly reduces quality of life, manifesting through dynamic changes in the musculoskeletal and sarcopenic systems, increased cardiovascular risks, dystrophic processes of the genitourinary tract, adverse […]<\/p>\n","protected":false},"author":12,"featured_media":22322,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1651],"tags":[6340,6367,6366,6341],"class_list":["post-22320","post","type-post","status-publish","format-standard","has-post-thumbnail","category-insight","tag-early-menopause","tag-maka-gegechkori","tag-premature-ovarian-insufficiency","tag-reproductive-health"],"acf":[],"_links":{"self":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts\/22320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/comments?post=22320"}],"version-history":[{"count":2,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts\/22320\/revisions"}],"predecessor-version":[{"id":22327,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts\/22320\/revisions\/22327"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/media\/22322"}],"wp:attachment":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/media?parent=22320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/categories?post=22320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/tags?post=22320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}